Globus Medical Inc [NYSE: GMED] stock went on a downward path that fall over -4.82% on Thursday, amounting to a one-week price decrease of less than -5.55%.
Over the last 12 months, GMED stock rose by 69.26%. The one-year Globus Medical Inc stock forecast points to a potential upside of 10.18. The average equity rating for GMED stock is currently 1.81, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $11.98 billion, with 113.47 million shares outstanding and 112.72 million shares in the current float. Compared to the average trading volume of 1.09M shares, GMED stock reached a trading volume of 4417849 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Globus Medical Inc [GMED]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GMED shares is $97.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GMED stock is a recommendation set at 1.81. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for Globus Medical Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, Morgan Stanley dropped their target price from $83 to $100. The new note on the price target was released on December 02, 2024, representing the official price target for Globus Medical Inc stock. Previously, the target price had yet another raise from $60 to $78, while Wells Fargo kept a Overweight rating on GMED stock. On May 20, 2024, analysts increased their price target for GMED shares from 60 to 80.
The Average True Range (ATR) for Globus Medical Inc is set at 2.38, with the Price to Sales ratio for GMED stock in the period of the last 12 months amounting to 4.83. The Price to Book ratio for the last quarter was 2.94, with the Price to Cash per share for the same quarter was set at 5.10. Price to Free Cash Flow for GMED in the course of the last twelve months was 40.77 with Quick ratio for the last quarter at 1.64.
GMED Stock Performance Analysis:
Globus Medical Inc [GMED] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.55. With this latest performance, GMED shares gained by 4.79% in over the last four-week period, additionally plugging by 27.37% over the last 6 months – not to mention a rise of 69.26% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GMED stock in for the last two-week period is set at 43.80, with the RSI for the last a single of trading hit 32.69, and the three-weeks RSI is set at 49.97 for Globus Medical Inc [GMED]. The present Moving Average for the last 50 days of trading for this stock 86.45, while it was recorded at 91.57 for the last single week of trading, and 73.51 for the last 200 days.
Insight into Globus Medical Inc Fundamentals:
Globus Medical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.64 and a Current Ratio set at 2.51.
GMED Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GMED. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Globus Medical Inc go to 19.17%.
Globus Medical Inc [GMED] Institutonal Ownership Details
There are presently around $97.89%, or 98.62%% of GMED stock, in the hands of institutional investors. The top three institutional holders of GMED stocks are: VANGUARD GROUP INC with ownership of 10.67 million shares, which is approximately 7.8857%. BLACKROCK INC., holding 10.34 million shares of the stock with an approximate value of $$708.18 million in GMED stocks shares; and BLACKROCK INC., currently with $$505.79 million in GMED stock with ownership which is approximately 5.4558%.
